# OnCo record state-biomarker-testing-laws (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/state-biomarker-testing-laws/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "state-biomarker-testing-laws" ;
  schema:name "State biomarker testing coverage laws"@en ;
  schema:alternateName "biomarker testing coverage law"@en, "biomarker testing coverage laws"@en, "biomarker testing legislation"@en, "comprehensive biomarker testing coverage"@en ;
  schema:description "A wave of US state laws, starting in 2021, that require insurers regulated by the state and often Medicaid to pay for the tumour and inherited gene tests that decide which targeted drug a patient should get."@en ;
  schema:url <https://onco.cc/terms/state-biomarker-testing-laws/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.fightcancer.org/policy-resources/improving-access-biomarker-testing> ;
  onco:tag "law", "us" ;
  onco:related <https://onco.cc/terms/medicare-ced/>, <https://onco.cc/terms/companion-diagnostic-term/>, <https://onco.cc/technologies/germline-testing/>, <https://onco.cc/terms/fda-ldt-rule/>, <https://onco.cc/terms/hta/>, <https://onco.cc/terms/financial-toxicity/>, <https://onco.cc/terms/gina/> ;
  onco:technologies <https://onco.cc/technologies/companion-diagnostic/>, <https://onco.cc/technologies/germline-testing/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-biomarker-validation/>, <https://onco.cc/bottlenecks/b-care-fragmentation/> .